Renal Failure
262
15
21
155
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
30 trials with published results (11%)
Research Maturity
155 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.4%
22 terminated out of 262 trials
87.6%
+1.1% vs benchmark
17%
45 trials in Phase 3/4
19%
30 of 155 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 155 completed trials
Clinical Trials (262)
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Premarket Clinical Safety Assessment of the ELISIO™-HX
Advanced Ultrasound Applications for Predicting AVF Outcomes
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Post-Filter Hematocrit
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Prevent Cardiac Surgery Associated AKI Trial
Improving Patient Prioritization During Hospital-homecare Transition
Assessment of Renal Function in Cirrhotic Patients
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
Analysis of Paediatric Treatments With multiFiltratePRO
Assessment of Organ Failure Risk Predictions in ICU
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes